| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 02/01/2006 | EP0898478B1 Stimulation of host defence mechanisms against tumors |
| 02/01/2006 | CN1729197A Tetracyclic 3-substituted indoles having serotonin receptor affinity |
| 02/01/2006 | CN1729192A Optical resolution of (1-benzyl-4-methylpiperidin-3-yl) -methylamine and the use thereof for the preparation of pyrrolo 2,3-pyrimidine derivatives as protein kinases inhibitors |
| 02/01/2006 | CN1729187A Substituted benzodioxepins |
| 02/01/2006 | CN1729185A Nobel compounds having selective inhibiting effect at GSK3 |
| 02/01/2006 | CN1729181A Novel tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 02/01/2006 | CN1729180A Piperazinyl and diazapanyl benzamides and benzthioamides |
| 02/01/2006 | CN1729000A Substituted alkyl-pyridazinones for the treatment of memory and learning malfunctions |
| 02/01/2006 | CN1728999A Substituted 1-piperidin-3-yl-4-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists |
| 02/01/2006 | CN1728989A Use of extracts containing phytoestrogen selectively modulating estrogen-receptor-beta. |
| 02/01/2006 | CN1728985A Bupropion hydrochloride solid dosage forms |
| 02/01/2006 | CN1727339A Tricyclic compounds, their production and use |
| 02/01/2006 | CN1726996A Rehabilitation powder for epilepsy |
| 02/01/2006 | CN1726990A Natural Chinese herbal medicine containing effective alkaloid in application for drug-relief medicine, and extracting technique |
| 02/01/2006 | CN1726955A Compound soft capsule of earthworm and preparation method |
| 02/01/2006 | CN1726934A Medication combination of Xuefu Zhuyu in application for preparing hypolipidemic |
| 02/01/2006 | CN1726931A Method for preparing medication of gastrodia tuber and tuber of multiflower knotweed |
| 02/01/2006 | CN1726915A Nasal cavity taken drug system and combination of naloxone hydrochloride and preparation method |
| 02/01/2006 | CN1726914A Slow release tablet of rotundine and production process |
| 02/01/2006 | CN1726911A Controlled release preparation of huperizine |
| 02/01/2006 | CN1240259C Method for forming holes, using flexible connection board formed thereof and its producing method |
| 02/01/2006 | CN1239497C Intermediate product for preparing aralkyl and aryl alkylene heterocyclic lactam and imide |
| 02/01/2006 | CN1239490C Method for preparing sitaipulan |
| 02/01/2006 | CN1239486C Acridine derivative and its application |
| 02/01/2006 | CN1239482C Positive modulators for nicotinic receptor agonists |
| 02/01/2006 | CN1239203C Hydrogel composition for transdermal drug delivery |
| 02/01/2006 | CN1239193C Chinese medicine for treating trigeminal neuralgia and its preparation method |
| 02/01/2006 | CN1239191C Chinese patent medicine for treating vascular dementia |
| 02/01/2006 | CN1239178C Method for preparing qingkailing granules |
| 02/01/2006 | CN1239162C Pain killing medicine composition |
| 02/01/2006 | CN1239160C Hormone replacement therapy |
| 02/01/2006 | CN1239158C 2-methyl-thieno-benzodiazepine formulation |
| 02/01/2006 | CN1239154C 5-HT IA receptor subtype agonist |
| 01/31/2006 | US6992219 Invention provides five novel polymorphic forms of modafinil racemate called CRL 40476 form III, CRL 40476 form IV, CRL 40476 form V, CRL 40476 form VI, CRL 40476 form VII; treatment of sleep disorders |
| 01/31/2006 | US6992215 Thiol-based NAALADase inhibitors |
| 01/31/2006 | US6992211 Crystalline form of phenylethanolamine, the preparation thereof and pharmaceutical compositions comprising the same |
| 01/31/2006 | US6992198 Method for the preparation of citalopram |
| 01/31/2006 | US6992171 Polypeptide and its DNA |
| 01/31/2006 | US6992110 Subclass of non-tricyclics which inhibit the reuptake of norepinephrine equal to or more than serotonin; milnacipran |
| 01/31/2006 | US6992103 amidation and/or dehalogenation to form substituted [4-carbamoyl-2-hydroxypentyl]-benzamides; potent enzyme inhibitors of Asp2 [B-secretase, BACE1 (b-site Alzheimer's amyloid precursor protein cleaving enzyme) or Memapsin]; Alzheimer's disease |
| 01/31/2006 | US6992095 Stilbene compounds comprising an adamantyl group, compositions and methods thereof |
| 01/31/2006 | US6992085 Octahydro-2H-pyrido[1,2-a]pyrazine compounds |
| 01/31/2006 | US6992084 Compounds and methods for modulating CXCR3 function |
| 01/31/2006 | US6992083 Benzoxazol derivatives |
| 01/31/2006 | US6992077 Spirocyclic ligands for sigma receptors, and libraries and methods of use thereof |
| 01/31/2006 | US6992074 2-Ethyl and 2-ethylidene-19-nor-vitamin D compounds |
| 01/31/2006 | US6992064 Central nervous system disorders; antidepressants |
| 01/31/2006 | US6991817 Acid-modified arabinogalactan protein composition |
| 01/31/2006 | US6991806 Pharmaceutical compositions comprising ibuprofen and domperidone |
| 01/31/2006 | US6991785 Administering by tissue absorption |
| 01/31/2006 | CA2327498C Process for alkylating hindered sulfonamides useful in the production of matrix metalloproteinase inhibitors |
| 01/31/2006 | CA2314154C Azepine or larger medium ring derivatives and their use as pharmaceuticals |
| 01/31/2006 | CA2171627C Rectally-administered, epileptic-seizure-inhibiting composition |
| 01/31/2006 | CA2149924C Use of phenserine to treat cognitive disorders |
| 01/26/2006 | WO2006009975A2 Histamine to treat disorders affecting muscle function |
| 01/26/2006 | WO2006009241A1 Lrp4/CORIN DOPAMINE-PRODUCING NEURON PRECURSOR CELL MARKER |
| 01/26/2006 | WO2006009114A1 Il-18 receptor antagonist and pharmaceutical composition containing the antagonist |
| 01/26/2006 | WO2006009093A1 Medicament for preventing and/or treating sleep disorder |
| 01/26/2006 | WO2006009092A1 Method of effectively using medicine and method concerning prevention of side effect |
| 01/26/2006 | WO2006008582A1 Treatment of neurological disorders with hematopoeitic growth factors |
| 01/26/2006 | US20060020138 E.g., 3-arylmethyl-7-hydroxy-coumarins as intermediates; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia |
| 01/26/2006 | US20060020040 Bupropion hydrochloride solid dosage forms |
| 01/26/2006 | US20060020028 Levodopa prodrugs, and compositions and uses thereof |
| 01/26/2006 | US20060020020 Regulators of the hedgehog pathway, compositions and uses related thereto |
| 01/26/2006 | US20060020002 (3a alpha ,4 alpha ,7 alpha ,7a alpha )-Octahydro-3-hydroxy-2-[4-nitro-3-(trifluoromethyl)phenyl]-4,7-methano-1H-isoindol-1-one (2); steroid mimic; competitive inhibitors of intercellular ligand binding reactions involving CAMs and Leukointegrins; anticarcinogenic agent; autoimmune diseases |
| 01/26/2006 | US20060019999 Specific inhibitors of one or more isoforms of nitric oxide synthase; 3-[[2-amino-1-phenylethyl]thio]-5-methyl-2-thiophenecarbonitrile; antiinflammatory agent; pain |
| 01/26/2006 | US20060019996 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 01/26/2006 | US20060019995 2,3-dihydro-4(1H)-pyridone derivatives , method for production thereof and pharmaceutical composition comprising the same |
| 01/26/2006 | US20060019983 Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3 and neuronal nicotinic receptor antagonists |
| 01/26/2006 | US20060019982 For therapy of central nervous system disorders, immunomodulatory disorders, antimalaria, viral disease of Borna virus, Hepatitis; a 6-azatricyclo(6.3.1.01,6)dodecane derivatives |
| 01/26/2006 | US20060019977 Spiroheterocyclic derivative compounds and drugs comprising the compound as the active ingredient |
| 01/26/2006 | US20060019970 Methods and compositions for the treatment of neuroleptic and related disorders using ziprasidone metabolites |
| 01/26/2006 | US20060019945 Granzyme b inhibitors |
| 01/26/2006 | US20060019882 Use of Yops as caspase inhibitor |
| 01/26/2006 | US20060019294 Tyrosine kinase substrate (Tks) proteins |
| 01/26/2006 | US20060019261 RNA-binding protein |
| 01/26/2006 | US20060018962 Sustained release formulation of tramadol |
| 01/26/2006 | US20060018825 Probe for diseases with amyloid accumulation, amyloid-staining agent, remedy and preventive for diseases with amyloid accumulation and diagnostic probe and staining agent for neurofibrillary change |
| 01/26/2006 | DE202005016250U1 Topiramat und pharmazeutische Formulierungen davon Topiramate and pharmaceutical formulations thereof |
| 01/26/2006 | DE102004030409A1 Neue Verwendung von Meloxicam in der Veterinärmedizin Novel use of meloxicam in veterinary medicine |
| 01/26/2006 | CA2579724A1 Amino-5,5-diphenylimidazolone derivatives for the inhibition of beta-secretase |
| 01/26/2006 | CA2578600A1 Diphenylimidazopyrimidine and -imidazole amines as inhibitors of b-secretase |
| 01/26/2006 | CA2574475A1 Indolone derivatives, processes for preparing them and their uses |
| 01/26/2006 | CA2574359A1 Arylacetic acids and related compounds for treatment of alzheimer's disease |
| 01/26/2006 | CA2574237A1 Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof |
| 01/26/2006 | CA2574193A1 Benzothiazole derivatives as adenosine receptor ligands |
| 01/26/2006 | CA2574180A1 Substituted benzothiazoles |
| 01/26/2006 | CA2574177A1 Lrp4/corin dopaminergic neuron progenitor cell markers |
| 01/26/2006 | CA2573915A1 Preventive and/or therapeutic agent for sleeping disorder |
| 01/26/2006 | CA2573673A1 Muscarinic antagonists with parp and sir modulating activity as cytoprotective agents |
| 01/26/2006 | CA2572822A1 Dimeric piperidine derivatives |
| 01/26/2006 | CA2572821A1 Dimeric compounds of piperidine, piperazine or morpholine or their 7-membered analogs suitable for the treatment of neurodegenerative disorders |
| 01/26/2006 | CA2572558A1 Methods of treating neurological conditions with hematopoeitic growth factors |
| 01/26/2006 | CA2572047A1 Octahydropyrrolo[2,3,c]pyridine derivatives and pharmaceutical use thereof |
| 01/26/2006 | CA2571881A1 Heterocyclic derivatives for modulation of calcium channels |
| 01/25/2006 | EP1619244A1 Method for inducing neural differentiation |
| 01/25/2006 | EP1619193A1 Spiropiperidine compound and medicinal use thereof |
| 01/25/2006 | EP1619192A2 Aryl fused azapolycyclic compounds |
| 01/25/2006 | EP1619182A1 Substance exhibiting antidepressant property |
| 01/25/2006 | EP1618882A2 Estrogen compositions for neuroprotection |